+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ritonavir"

COVID-19 Current Therapy Global Market Report 2024 - Product Thumbnail Image

COVID-19 Current Therapy Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
HIV Drugs Global Market Report 2024 - Product Thumbnail Image

HIV Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Antivirals Global Market Report 2024 - Product Thumbnail Image

Antivirals Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026 - Product Thumbnail Image

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026

  • Report
  • February 2021
  • 360 Pages
  • United States
From
Coronavirus (COVID-19) Current Therapy Global Market Report 2023 - Product Thumbnail Image

Coronavirus (COVID-19) Current Therapy Global Market Report 2023

  • Report
  • February 2023
  • 250 Pages
  • Global
From
From
From
From
Pregnancy and Anti-Infective Agents - Product Thumbnail Image

Pregnancy and Anti-Infective Agents

  • Book
  • November 2020
From
  • 15 Results (Page 1 of 1)
Loading Indicator

Ritonavir is an antiretroviral drug used to treat HIV/AIDS. It is a protease inhibitor, meaning it blocks the action of the HIV protease enzyme, which is necessary for the virus to replicate. Ritonavir is used in combination with other antiretroviral drugs to treat HIV infection. It is also used to treat hepatitis C virus (HCV) infection in combination with other antiviral drugs. Ritonavir is available in both oral and intravenous formulations. Ritonavir is a widely used drug in the treatment of infectious diseases. It is used in combination with other antiretroviral drugs to treat HIV infection, and is also used to treat HCV infection in combination with other antiviral drugs. Ritonavir is also used to treat other viral infections, such as influenza and respiratory syncytial virus (RSV). Some companies in the Ritonavir market include AbbVie, Bristol-Myers Squibb, Gilead Sciences, Merck, and Pfizer. Show Less Read more